Amundson, Sally A.
Belli, Mauro
Blettner, Maria
Borgmann, Kerstin
Forssell-Aronsson, Eva
Harms-Ringdahl, Mats
Jeggo, Penelope A.
Niwa, Ohtsura
O’Neill, Peter
Article History
Received: 5 February 2025
Accepted: 18 March 2025
First Online: 28 March 2025
Declarations
:
: In the European context it is currently assumed that a low dose is < 100 mGy for low LET radiations when considering cancer risks, and < 500 mGy when considering non-cancer diseases, and low dose rates at < 6 mGy/h (SRA of MELODI 2022. ).
: The authors declare no competing interests.